SA4503 8-Week Study in Major Depressive Disorder (MDD)

Update Il y a 5 ans
Reference: NCT00551109

Woman and Man

  • | Country :
  • Finland
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The purpose of this study is to determine the efficacy of SA4503 compared to placebo in the treatment of subjects with major depressive disorder (MDD). Secondary, to evaluate the safety of SA4503 compared to placebo in subjects with MDD.


Inclusion criteria

  • Depressive Disorder, Major

Links